amlodipine besylate and benazepril hydrochloride
amlodipine besylate and benazepril hydrochloride is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand name including Lotrel. Available dosage form: capsule.
Drug Details
- Generic Name
- amlodipine besylate and benazepril hydrochloride
- Brand Names
- Lotrel
- Application Number
- NDA020364
- Sponsor
- Novartis Pharmaceuticals Corporation
- NDC Codes
- 4
- Dosage Forms
- CAPSULE
- Routes
- ORAL
- Active Ingredients
- AMLODIPINE BESYLATE, BENAZEPRIL HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE Amlodipine and benazepril hydrochloride capsule, is a combination capsule of amlodipine, a dihydropyridine calcium channel blocker (DHP CCB) and benazepril, an angiotensin converting-enzyme (ACE) inhibitor. Amlodipine and benazepril hydrochloride capsule, is indicated for the treatment of hypertension in patients not adequately controlled on monotherapy with either agent ( 1 ). 1.1 Hypertension Amlodipine and benazepril hydrochloride capsules, are indicated for the treatment of hypertension in patients not adequately controlled on monotherapy with either agent.